{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33273692", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "06", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "12", "Day": "03"}], "Language": ["eng"], "ELocationID": ["732", "10.1038/s42003-020-01458-3"], "Journal": {"ISSN": "2399-3642", "JournalIssue": {"Volume": "3", "Issue": "1", "PubDate": {"Year": "2020", "Month": "Dec", "Day": "03"}}, "Title": "Communications biology", "ISOAbbreviation": "Commun Biol"}, "ArticleTitle": "A C21-steroidal derivative suppresses T-cell lymphoma in mice by inhibiting SIRT3 via SAP18-SIN3.", "Pagination": {"StartPage": "732", "MedlinePgn": "732"}, "Abstract": {"AbstractText": ["The SIN3 repressor complex and the NAD-dependent deacetylase SIRT3 control cell growth, and development as well as malignant transformation. Even then, a little known about cross-talks between these two chromatin modifiers or whether their interaction explored therapeutically. Here we describe the identification of a C<sub>21</sub>-steroidal derivative compound, 3-O-chloroacetyl-gagamine, A671, which potently suppresses the growth of mouse and human T-cell lymphoma and erythroleukemia in vitro and preclinical models. A671 exerts its anti-neoplastic effects by direct interaction with Histone deacetylase complex subunit SAP18, a component of the SIN3 suppressor complex. This interaction stabilizes and activates SAP18, leading to transcriptional suppression of SIRT3, consequently to inhibition of proliferation and cell death. The resistance of cancer cells to A671 correlated with diminished SAP18 activation and sustained SIRT3 expression. These results uncover the SAP18-SIN3-SIRT3 axis that can be pharmacologically targeted by a C<sub>21</sub>-steroidal agent to suppress T-cell lymphoma and other malignancies."]}, "AuthorList": [{"Identifier": ["0000-0001-5764-581X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biochemistry, Dr. A.L.M. Post Graduate Institute of Basic Medical Sciences, University of Madras, Taramani Campus, Chennai, 600113, India."}], "LastName": "Varier", "ForeName": "Krishnapriya M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The National Health Commission's Key Laboratory of Immunological Pulmonary Disease, Guizhou Provincial People's Hospital, The Affiliated Hospital of Guizhou University, Guiyang, Guizhou, 550002, China."}], "LastName": "Sample", "ForeName": "Klarke M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, M5G 2M1, ON, Canada."}, {"Identifier": [], "Affiliation": "Division of Advanced Diagnostics, Toronto General Research Institute-University Health Network, Toronto, ON, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Cancer Center of the First Hospital of Jilin University, Changchun, Jilin, 130021, China."}], "LastName": "Juiwei", "ForeName": "Cui", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. huangliejun@126.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, China. huangliejun@126.com."}], "LastName": "Huang", "ForeName": "LieJun", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. haoxj@mail.kib.ac.cn."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, China. haoxj@mail.kib.ac.cn."}], "LastName": "Hao", "ForeName": "XiaoJiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, 550014, China. yaacovbendavid@hotmail.com."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, 550014, China. yaacovbendavid@hotmail.com."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Commun Biol", "NlmUniqueID": "101719179", "ISSNLinking": "2399-3642"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Co-Repressor Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA-Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "SAP18 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Sap18 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Sap30 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Sirt3 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Steroids"}, {"RegistryNumber": "EC 3.5.1.-", "NameOfSubstance": "SIRT3 protein, human"}, {"RegistryNumber": "EC 3.5.1.-", "NameOfSubstance": "Sirtuin 3"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "Histone Deacetylases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Co-Repressor Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Histone Deacetylases"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Lymphoma, T-Cell"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Protein Conformation"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA-Binding Proteins"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Sirtuin 3"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Steroids"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Laurie HS, Soulier J. Introduction to the review series on T-cell malignancies. Blood. 2017;129:1059\u20131060. doi: 10.1182/blood-2017-01-741389.", "ArticleIdList": ["10.1182/blood-2017-01-741389", "28115370"]}, {"Citation": "Ma H, Abdul-Hay M. T-cell lymphomas, a challenging disease: types, treatments, and future. Int. J. Clin. Oncol. 2017;22:18\u201351. doi: 10.1007/s10147-016-1045-2.", "ArticleIdList": ["10.1007/s10147-016-1045-2", "PMC7102240", "27743148"]}, {"Citation": "Durinck K, et al. Novel biological insights in T-cell acute lymphoblastic leukemia. Exp. Hematol. 2015;43:625\u201339. doi: 10.1016/j.exphem.2015.05.017.", "ArticleIdList": ["10.1016/j.exphem.2015.05.017", "26123366"]}, {"Citation": "Utsunomiya A, et al. Recent advances in the treatment of adult T-cell leukemia-lymphomas. Cancer Sci. 2015;106:344\u201351. doi: 10.1111/cas.12617.", "ArticleIdList": ["10.1111/cas.12617", "PMC4409876", "25613789"]}, {"Citation": "Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat. Rev. Cancer. 2007;7:270\u201380. doi: 10.1038/nrc2111.", "ArticleIdList": ["10.1038/nrc2111", "17384582"]}, {"Citation": "Jain S, Zain J, O\u2019Connor O. Novel therapeutic agents for cutaneous T-cell lymphoma. J. Hematol. Oncol. 2012;5:1\u201315. doi: 10.1186/1756-8722-5-24.", "ArticleIdList": ["10.1186/1756-8722-5-24", "PMC3418166", "22594538"]}, {"Citation": "Rouce RH, et al. Recent advances in T-cell immunotherapy for haematological malignancies. Br. J. Haematol. 2017;176:688\u2013704. doi: 10.1111/bjh.14470.", "ArticleIdList": ["10.1111/bjh.14470", "PMC5318250", "27897332"]}, {"Citation": "Ansell S. How to select the frontline treatment for a patient with peripheral T-cell lymphoma. Leuk. Lymphoma. 2016;57:783\u2013788. doi: 10.3109/10428194.2016.1140760.", "ArticleIdList": ["10.3109/10428194.2016.1140760", "26850659"]}, {"Citation": "Qu K, et al. Chromatin accessibility landscape of cutaneous T cell lymphoma and dynamic response to HDAC Inhibitors. Cancer Cell. 2017;32:27\u201341. doi: 10.1016/j.ccell.2017.05.008.", "ArticleIdList": ["10.1016/j.ccell.2017.05.008", "PMC5559384", "28625481"]}, {"Citation": "Apuri S, Sokol L. An overview of investigational Histone deacetylase inhibitors (HDACis) for the treatment of non-Hodgkin\u2019s lymphoma. Expert Opin. Investig. Drugs. 2016;25:687\u2013696. doi: 10.1517/13543784.2016.1164140.", "ArticleIdList": ["10.1517/13543784.2016.1164140", "26954526"]}, {"Citation": "Marks PA. Discovery and development of SAHA as an anticancer agent. Oncogene. 2007;26:1351\u20131356. doi: 10.1038/sj.onc.1210204.", "ArticleIdList": ["10.1038/sj.onc.1210204", "17322921"]}, {"Citation": "VanderMolen KM, et al. Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma. J. Antibiot. 2011;64:525\u2013531. doi: 10.1038/ja.2011.35.", "ArticleIdList": ["10.1038/ja.2011.35", "PMC3163831", "21587264"]}, {"Citation": "Ueda H, et al. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity. J. Antibiot. 1994;47:301\u2013310. doi: 10.7164/antibiotics.47.301.", "ArticleIdList": ["10.7164/antibiotics.47.301", "7513682"]}, {"Citation": "Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 2007;5:981\u2013989. doi: 10.1158/1541-7786.MCR-07-0324.", "ArticleIdList": ["10.1158/1541-7786.MCR-07-0324", "17951399"]}, {"Citation": "Grzenda A, et al. Sin3: master scaffold and transcriptional corepressor. Biochim. Biophys. Acta. 2009;1789:443\u2013450. doi: 10.1016/j.bbagrm.2009.05.007.", "ArticleIdList": ["10.1016/j.bbagrm.2009.05.007", "PMC3686104", "19505602"]}, {"Citation": "Zhang Y, et al. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell. 1997;89:357\u2013364. doi: 10.1016/S0092-8674(00)80216-0.", "ArticleIdList": ["10.1016/S0092-8674(00)80216-0", "9150135"]}, {"Citation": "Ding X, et al. Suppression of the SAP18/HDAC1 complex by targeting TRIM56 and Nanog is essential for oncogenic viral FLICE-inhibitory protein-induced acetylation of p65/RelA, NF-kappaB activation, and promotion of cell invasion and angiogenesis. Cell Death Differ. 2019;26:1970\u20131986. doi: 10.1038/s41418-018-0268-3.", "ArticleIdList": ["10.1038/s41418-018-0268-3", "PMC6748093", "30670829"]}, {"Citation": "Onyango P, et al. SIRT3, a human SIR2 homologue, is an NAD- dependent deacetylase localized to mitochondria. Proc. Natl Acad. Sci. 2002;99:13653\u201313658. doi: 10.1073/pnas.222538099.", "ArticleIdList": ["10.1073/pnas.222538099", "PMC129731", "12374852"]}, {"Citation": "Scher MB, et al. SirT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev. 2007;21:920\u2013928. doi: 10.1101/gad.1527307.", "ArticleIdList": ["10.1101/gad.1527307", "PMC1847710", "17437997"]}, {"Citation": "Li M, et al. Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis. Cancer Cell. 2019;35:916\u2013931. doi: 10.1016/j.ccell.2019.05.002.", "ArticleIdList": ["10.1016/j.ccell.2019.05.002", "PMC7534582", "31185214"]}, {"Citation": "Chen Y, et al. Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 2014;5:1\u20137.", "ArticleIdList": ["PMC3944233", "24503539"]}, {"Citation": "Alhazzazi TY, et al. SIRT3 and cancer: tumor promoter or suppressor? Biochim. Biophys. Acta. 2011;1816:80\u201388.", "ArticleIdList": ["PMC3129516", "21586315"]}, {"Citation": "Huang LJ, et al. C21-steroidal pregnane sapogenins and their derivatives as anti-inflammatory agents. Bioorg. Med. Chem. 2017;25:3512\u20133524. doi: 10.1016/j.bmc.2017.04.045.", "ArticleIdList": ["10.1016/j.bmc.2017.04.045", "28506585"]}, {"Citation": "Howard JC, et al. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene. 1993;8:2721\u20132729.", "ArticleIdList": ["8378083"]}, {"Citation": "Ben-David Y, Bernstein A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell. 1991;66:831\u2013834. doi: 10.1016/0092-8674(91)90428-2.", "ArticleIdList": ["10.1016/0092-8674(91)90428-2", "1889087"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl Acad. Sci. 1990;87:1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Ben-David Y, et al. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5:908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Mottamal M, et al. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules. 2015;20:3898\u20133941. doi: 10.3390/molecules20033898.", "ArticleIdList": ["10.3390/molecules20033898", "PMC4372801", "25738536"]}, {"Citation": "West AC, Johnstone RW. New and emerging HDAC inhibitors for cancer treatment. J. Clin. Investig. 2014;124:30\u201339. doi: 10.1172/JCI69738.", "ArticleIdList": ["10.1172/JCI69738", "PMC3871231", "24382387"]}, {"Citation": "Wei Z, et al. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis. Nat. Commun. 2018;9:1\u201316. doi: 10.1038/s41467-017-02088-w.", "ArticleIdList": ["10.1038/s41467-017-02088-w", "PMC6203763", "30367038"]}, {"Citation": "Yu H, et al. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer. Clin. Cancer Res. 2014;20:3434\u20133445. doi: 10.1158/1078-0432.CCR-13-2952.", "ArticleIdList": ["10.1158/1078-0432.CCR-13-2952", "24771643"]}, {"Citation": "Yang H, et al. Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell. 2007;130:1095\u20131107. doi: 10.1016/j.cell.2007.07.035.", "ArticleIdList": ["10.1016/j.cell.2007.07.035", "PMC3366687", "17889652"]}, {"Citation": "Bui CB, et al. ARID1A-SIN3A drives retinoic acid-induced neuroblastoma differentiation by transcriptional repression of TERT. Mol. Carcinog. 2019;58:1998\u20132007. doi: 10.1002/mc.23091.", "ArticleIdList": ["10.1002/mc.23091", "31365169"]}, {"Citation": "Singh KK, et al. Human SAP18 mediates assembly of a splicing regulatory multiprotein complex via its ubiquitin-like fold. RNA. 2010;16:2442\u20132454. doi: 10.1261/rna.2304410.", "ArticleIdList": ["10.1261/rna.2304410", "PMC2995405", "20966198"]}, {"Citation": "Son DJ, et al. MMPP attenuates non-small cell lung cancer growth by inhibiting the STAT3 DNA-binding activity via direct binding to the STAT3 DNA-binding domain. Theranostics. 2017;7:4632\u20134642. doi: 10.7150/thno.18630.", "ArticleIdList": ["10.7150/thno.18630", "PMC5695154", "29158850"]}, {"Citation": "Zheng J, et al. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice. Oncotarget. 2015;6:41929\u201341943. doi: 10.18632/oncotarget.5861.", "ArticleIdList": ["10.18632/oncotarget.5861", "PMC4747199", "26474284"]}, {"Citation": "Ma J, et al. Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and promotes apoptosis of esophageal squamous cell lines. Mol. Med. Rep. 2015;11:4525\u20134531. doi: 10.3892/mmr.2015.3268.", "ArticleIdList": ["10.3892/mmr.2015.3268", "25634603"]}, {"Citation": "Han X, et al. CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3. Cell Death Dis. 2019;10:1\u201315. doi: 10.1038/s41419-018-1236-z.", "ArticleIdList": ["10.1038/s41419-018-1236-z", "PMC6687752", "31395859"]}, {"Citation": "Allison SJ, Milner J. SIRT3 is pro-apoptotic and participates in distinct basal apoptotic pathways. Cell Cycle. 2007;6:2669\u20132677. doi: 10.4161/cc.6.21.4866.", "ArticleIdList": ["10.4161/cc.6.21.4866", "17957139"]}, {"Citation": "Makishima S, et al. Sin3A-associated protein, 18 kDa, a novel binding partner of TRIB1, regulates MTTP expression. J. Lipid Res. 2015;56:1145\u20131152. doi: 10.1194/jlr.M057802.", "ArticleIdList": ["10.1194/jlr.M057802", "PMC4442872", "25921304"]}, {"Citation": "Bellei M, Federico M. The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective International T-Cell Project. Haematologica. 2019;104:e178. doi: 10.3324/haematol.2019.218305.", "ArticleIdList": ["10.3324/haematol.2019.218305", "PMC6442952", "30930340"]}, {"Citation": "Almeida AM, et al. Clinical outcomes of 217 patients with acute erythroleukemia according to treatment type and line: a retrospective multinational study. Int. J. Mol. Sci. 2017;18:1\u201316. doi: 10.3390/ijms18040837.", "ArticleIdList": ["10.3390/ijms18040837", "PMC5412421", "28420120"]}, {"Citation": "Liu T, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8:16728\u201316743. doi: 10.18632/oncotarget.14377.", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Liu T, et al. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10:1\u201311. doi: 10.1038/s41419-018-1236-z.", "ArticleIdList": ["10.1038/s41419-018-1236-z", "PMC6370842", "30741932"]}, {"Citation": "Yu W, et al. Loss of SIRT3 provides growth advantage for B cell malignancies. J. Biol. Chem. 2016;291:3268\u20133279. doi: 10.1074/jbc.M115.702076.", "ArticleIdList": ["10.1074/jbc.M115.702076", "PMC4751373", "26631723"]}, {"Citation": "Egnatchik RA, et al. Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertension. Pulm. Circ. 2017;7:186\u2013199. doi: 10.1086/690236.", "ArticleIdList": ["10.1086/690236", "PMC5448547", "28680578"]}, {"Citation": "Thorne N, Auld DS, Inglese J. Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr. Opin. Chem. Biol. 2010;14:315\u2013324. doi: 10.1016/j.cbpa.2010.03.020.", "ArticleIdList": ["10.1016/j.cbpa.2010.03.020", "PMC2878863", "20417149"]}, {"Citation": "Morris GM, et al. Auto-Dock 4 and AutoDockTools 4: automated docking with selective receptor flexibility. J. Comput. Chem. 2009;30:2785\u20132791. doi: 10.1002/jcc.21256.", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Wang N, et al. Selective ERK1/2 agonists isolated from Melia azedarach with potent anti-leukemic activity. BMC Cancer. 2019;19:764. doi: 10.1186/s12885-019-5914-8.", "ArticleIdList": ["10.1186/s12885-019-5914-8", "PMC6679490", "31375085"]}, {"Citation": "Cerami E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401\u2013404. doi: 10.1158/2159-8290.CD-12-0095.", "ArticleIdList": ["10.1158/2159-8290.CD-12-0095", "PMC3956037", "22588877"]}, {"Citation": "Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013;6:1. doi: 10.1126/scisignal.2004088.", "ArticleIdList": ["10.1126/scisignal.2004088", "PMC4160307", "23550210"]}, {"Citation": "Kazachenka A, et al. Identification, characterization, and heritability of murine metastable epialleles: implications for non-genetic inheritance. Cell. 2018;175:1259\u20131271. doi: 10.1016/j.cell.2018.09.043.", "ArticleIdList": ["10.1016/j.cell.2018.09.043", "PMC6242299", "30454646"]}, {"Citation": "Inoue F, et al. A systematic comparison reveals substantial differences in chromosomal versus episomal encoding of enhancer activity. Genome Res. 2017;27:38\u201352. doi: 10.1101/gr.212092.116.", "ArticleIdList": ["10.1101/gr.212092.116", "PMC5204343", "27831498"]}]}], "History": [{"Year": "2020", "Month": "4", "Day": "20"}, {"Year": "2020", "Month": "11", "Day": "2"}, {"Year": "2020", "Month": "12", "Day": "4", "Hour": "5", "Minute": "44"}, {"Year": "2020", "Month": "12", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "12", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["33273692", "PMC7713351", "10.1038/s42003-020-01458-3", "10.1038/s42003-020-01458-3"]}}]}